نتائج البحث - Fraser Cummings

تنقيح النتائج
  1. 1
    JAK1 inhibition and inflammatory bowel disease

    JAK1 inhibition and inflammatory bowel disease حسب Clare Harris, Fraser Cummings

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  2. 2
    Medical management of Crohn’s disease

    Medical management of Crohn’s disease حسب Fraser Cummings, Satish Keshav, Simon Travis

    منشور في 2008
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  3. 3
    Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence

    Adalimumab Biosimilars in Europe: An Overview of the Clinical Evidence حسب Salvatore Bellinvia, Fraser Cummings, Michael R. Ardern‐Jones, Christopher J Edwards

    منشور في 2019
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  4. 4
    Life in lockdown: experiences of patients with IBD during COVID-19

    Life in lockdown: experiences of patients with IBD during COVID-19 حسب Richard Harris, Louise Downey, Trevor Smith, Fraser Cummings, Richard Felwick, Markus Gwiggner

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  5. 5
    Oral methotrexate in ulcerative colitis

    Oral methotrexate in ulcerative colitis حسب Fraser Cummings, Klaus R. Herrlinger, Simon Travis, Stephen Gorard, A. S. McIntyre, D P Jewell

    منشور في 2005
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  6. 6
    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease

    Human Intestinal Macrophages Are Involved in the Pathology of Both Ulcerative Colitis and Crohn Disease حسب Suranga Dharmasiri, Eva M. Garrido-Martín, Richard Harris, Adrian C Bateman, Jane Collins, Fraser Cummings, Tilman Sanchez‐Elsner

    منشور في 2021
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  7. 7
    QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study

    QT and QTc dispersion are accurate predictors of cardiac death in newly diagnosed non-insulin dependent diabetes: cohort study حسب A. A O Naas, Neil C. Davidson, C. Thompson, Fraser Cummings, S. Ogston, R. T. Jung, Richard Newton, Allan D. Struthers

    منشور في 1998
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  8. 8
    MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1

    MicroRNA-31 and MicroRNA-155 Are Overexpressed in Ulcerative Colitis and Regulate IL-13 Signaling by Targeting Interleukin 13 Receptor α-1 حسب Markus Gwiggner, Rocío T. Martínez-Nuñez, Simon Whiteoak, Victor P. Bondanese, A Claridge, Jane Collins, Fraser Cummings, Tilman Sanchez‐Elsner

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  9. 9
    Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis

    Th17 Cells Expressing KIR3DL2+ and Responsive to HLA-B27 Homodimers Are Increased in Ankylosing Spondylitis حسب Paul Bowness, Anna Ridley, Jacqueline Shaw, Antoni Chan, Isabel Wong‐Baeza, Myles Fleming, Fraser Cummings, Andrew J. McMichael, Simon Kollnberger

    منشور في 2011
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  10. 10
    Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype

    Contribution of the novel inflammatory bowel disease gene IL23R to disease susceptibility and phenotype حسب Fraser Cummings, Tariq Ahmad, Alessandra Geremia, John Beckly, Rachel Cooney, Laura Hancock, Saad Pathan, Changcun Guo, Lon R. Cardon, Derek P. Jewell

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  11. 11
    Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS]

    Transitioning from Intravenous to Subcutaneous Vedolizumab in Patients with Inflammatory Bowel Disease [TRAVELESS] حسب Esther Ventress, David Young, Sohail Rahmany, Clare Harris, Marion Bettey, Trevor Smith, Helen Moyses, Magdalena Lech, Markus Gwiggner, Richard Felwick, Fraser Cummings

    منشور في 2021
    احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  12. 12
    The pattern and outcome of acute severe colitis

    The pattern and outcome of acute severe colitis حسب Lotte C. Dinesen, Alissa Walsh, Marijana Nedeljkovic Protic, Graham Heap, Fraser Cummings, Bryan F. Warren, Bruce George, N J McC Mortensen, Simon Travis

    منشور في 2010
    احصل على النص الكامل
    Revisão
    أضف إلى المفضلة
    محفوظ في:
  13. 13
    Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients

    Food-related quality of life is impaired in inflammatory bowel disease and associated with reduced intake of key nutrients حسب Kevin Whelan, Trevor Murrells, Myfanwy Morgan, Fraser Cummings, Catherine Stansfield, Anne Todd, Shaji Sebastian, Alan Lobo, Miranda Lomer, James O. Lindsay, Wladyslawa Czuber‐Dochan

    منشور في 2020
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  14. 14
    Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial

    Subcutaneous Infliximab Monotherapy Versus Combination Therapy with Immunosuppressants in Inflammatory Bowel Disease: A Post Hoc Analysis of a Randomised Clinical Trial حسب Geert D’Haens, Walter Reinisch, Stefan Schreiber, Fraser Cummings, Peter M. Irving, Byong Duk Ye, Dong‐Hyeon Kim, Sang-Wook Yoon, Shomron Ben–Horin

    منشور في 2023
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  15. 15
    Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme

    Biosimilar Infliximab in Inflammatory Bowel Disease: Outcomes of a Managed Switching Programme حسب Violeta Razanskaite, Marion Bettey, Louise Downey, Julia L. Wright, J Callaghan, Miles Rush, Simon Whiteoak, Sarah Ker, Kim Perry, Caron Underhill, Efrem Eren, Iftikar Ahmed, Fraser Cummings

    منشور في 2017
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  16. 16
    P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics

    P245 Biologics Sequencing in Clinical Units (BISCUITS): Comparing outcomes in Crohn’s disease patients on second-line biologics حسب Giulia Bartalucci, Frederick R. Taylor, C. Gleave, Liz Dobson, Keith Bodger, Susanna Dodd, Stuart Bloom, Alun Passey, R Nissinen, Daniel Wirth, Darian Andreas, J Lee, Fraser Cummings

    منشور في 2024
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  17. 17
    Confirmation of the role of ATG16l1 as a Crohnʼs disease susceptibility gene

    Confirmation of the role of ATG16l1 as a Crohnʼs disease susceptibility gene حسب Fraser Cummings, Rachel Cooney, Saad Pathan, Carl A. Anderson, Jeffrey C. Barrett, John Beckly, Alessandra Geremia, Laura Hancock, Changcun Guo, Tariq Ahmad, Lon R. Cardon, Derek P. Jewell

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  18. 18
    Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach

    Consensus recommendations for patient-centered therapy in mild-to-moderate ulcerative colitis: the i Support Therapy–Access to Rapid Treatment (iSTART) approach حسب Silvio Danese, Rupa Banerjee, Fraser Cummings, Iris Dotan, Paulo Gustavo Kotze, Rupert W. Leong, Kristine Paridaens, Laurent Peyrin‐Biroulet, Glyn Scott, Gert Van Assche, Jan Wehkamp, Jesús K. Yamamoto‐Furusho

    منشور في 2018
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  19. 19
    IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease

    IL23R Variation Determines Susceptibility But Not Disease Phenotype in Inflammatory Bowel Disease حسب Mark Tremelling, Fraser Cummings, Sheila Fisher, John Mansfield, Rhian Gwilliam, Andrew Keniry, Elaine R. Nimmo, Hazel E. Drummond, Clive M. Onnie, Natalie J. Prescott, Jeremy Sanderson, Francesca Bredin, Carlo Berzuini, Alastair Forbes, Cathryn M. Lewis, Lon R. Cardon, Panos Deloukas, Derek P. Jewell, Christopher G. Mathew, Miles Parkes, Jack Satsangi

    منشور في 2007
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:
  20. 20
    Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres

    Real-world assessment of effectiveness and safety of filgotinib in 286 patients with ulcerative colitis in 9 UK centres حسب David Young, Sohail Rahmany, Deborah R. Taylor, E. A. Davis, Michael Colwill, Sonia Kalyanji Mehta, Roisin Campbell, Karl Hazel, Karishma Sethi-Arora, Susan Ritchie, Ashley Heinson, Helen Moyses, Keith Bodger, Emma Johnston, Lucy Hicks, Anjan Dhar, Jimmy K. Limdi, Rachel Cooney, John Paul Seenan, Kamal Patel, Alissa Walsh, Fraser Cummings

    منشور في 2025
    احصل على النص الكامل احصل على النص الكامل
    Artigo
    أضف إلى المفضلة
    محفوظ في:

أدوات البحث: